Kathmere Capital Management LLC Purchases 1,738 Shares of Leidos Holdings, Inc. (NYSE:LDOS)

Kathmere Capital Management LLC grew its holdings in shares of Leidos Holdings, Inc. (NYSE:LDOS - Free Report) by 64.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,439 shares of the aerospace company's stock after acquiring an additional 1,738 shares during the quarter. Kathmere Capital Management LLC's holdings in Leidos were worth $640,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. American Century Companies Inc. increased its holdings in shares of Leidos by 1.1% in the second quarter. American Century Companies Inc. now owns 168,881 shares of the aerospace company's stock worth $24,636,000 after buying an additional 1,812 shares during the period. DekaBank Deutsche Girozentrale grew its position in Leidos by 2.2% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 42,095 shares of the aerospace company's stock worth $6,273,000 after acquiring an additional 887 shares during the last quarter. Federated Hermes Inc. increased its stake in Leidos by 173.5% in the 2nd quarter. Federated Hermes Inc. now owns 1,381 shares of the aerospace company's stock worth $201,000 after purchasing an additional 876 shares during the period. Quantbot Technologies LP bought a new stake in Leidos in the second quarter valued at approximately $2,674,000. Finally, Renaissance Technologies LLC boosted its stake in shares of Leidos by 127.6% during the second quarter. Renaissance Technologies LLC now owns 301,050 shares of the aerospace company's stock valued at $43,917,000 after purchasing an additional 168,800 shares during the period. 76.12% of the stock is owned by hedge funds and other institutional investors.

Leidos Stock Down 0.2 %

LDOS traded down $0.28 during midday trading on Thursday, reaching $154.97. The company's stock had a trading volume of 649,660 shares, compared to its average volume of 1,098,516. The stock's 50-day moving average is $158.64 and its 200-day moving average is $157.89. Leidos Holdings, Inc. has a 1 year low of $107.73 and a 1 year high of $202.90. The firm has a market capitalization of $20.68 billion, a price-to-earnings ratio of 17.65, a PEG ratio of 0.98 and a beta of 0.66. The company has a current ratio of 1.23, a quick ratio of 1.15 and a debt-to-equity ratio of 0.87.

Leidos (NYSE:LDOS - Get Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The aerospace company reported $2.93 earnings per share for the quarter, beating analysts' consensus estimates of $1.96 by $0.97. Leidos had a return on equity of 30.31% and a net margin of 7.37%. The company had revenue of $4.19 billion during the quarter, compared to analyst estimates of $4.06 billion. During the same quarter last year, the company earned $2.03 EPS. The firm's revenue for the quarter was up 6.9% on a year-over-year basis. As a group, research analysts expect that Leidos Holdings, Inc. will post 10.03 EPS for the current year.

Leidos Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 31st. Investors of record on Monday, December 16th were given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.03%. This is an increase from Leidos's previous quarterly dividend of $0.38. The ex-dividend date was Monday, December 16th. Leidos's dividend payout ratio is 18.22%.

Insider Buying and Selling at Leidos

In other news, Director Surya N. Mohapatra sold 2,748 shares of the business's stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $194.97, for a total value of $535,777.56. Following the completion of the transaction, the director now owns 20,001 shares in the company, valued at $3,899,594.97. The trade was a 12.08 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Noel B. Geer purchased 2,000 shares of the stock in a transaction dated Wednesday, November 20th. The shares were acquired at an average cost of $161.13 per share, for a total transaction of $322,260.00. Following the completion of the acquisition, the director now owns 2,000 shares of the company's stock, valued at approximately $322,260. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.96% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the stock. Truist Financial lowered their price target on shares of Leidos from $205.00 to $185.00 and set a "buy" rating for the company in a report on Friday, November 22nd. Citigroup increased their target price on shares of Leidos from $194.00 to $220.00 and gave the stock a "buy" rating in a report on Wednesday, October 30th. UBS Group initiated coverage on Leidos in a report on Monday, December 2nd. They set a "neutral" rating and a $182.00 price target on the stock. Robert W. Baird increased their price objective on Leidos from $180.00 to $218.00 and gave the stock an "outperform" rating in a report on Wednesday, October 30th. Finally, Barclays boosted their target price on Leidos from $165.00 to $210.00 and gave the company an "overweight" rating in a research note on Monday, November 4th. Five equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $179.07.

Leidos Company Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.